Evidence map›Paper›PMID 37744082›Full record

ArticleStigma and health2023

Intersectional Stigma as a Fundamental Cause of Health Disparities: A case study of how drug use stigma intersecting with racism and xenophobia creates health inequities for Black and Hispanic persons who use drugs over time.

Suzan M Walters, Jelani Kerr, Manuel Cano, Valerie Earnshaw, Bruce Link

Open access · hybridAbstract read
In one paragraph

Article in Stigma and health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
20.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Should we embrace the term 'preaddiction'?Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Suzan M WaltersSchool of Global Public Health, New York University, New York, NY.
Jelani KerrDepartment of Health Promotion and Behavioral Sciences, University of Louisville, Louisville, KY.
Manuel CanoDepartment of Social Work, University of Texas at San Antonio, San Antonio, TX.
Valerie EarnshawDepartment of Human Development and Family Sciences, University of Delaware, Newark, DE.
Bruce LinkDepartment of Sociology, University of California Riverside, Riverside, CA.
New York University · USThe University of Texas at San Antonio · USUniversity of California, Riverside · USUniversity of Delaware · USUniversity of Louisville · US

Funding

Substance Use and HIV Prevention Research in Minority Communities Training ProgramR25DA028567 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Julia Lechuga, Torsten Brian Neilands · 2009 to 2026
$5.4M
Intersectional Stigma Experiences, Pre-exposure Prophylaxis (PrEP), and Other Service Use Among People Who Inject DrugsK01DA053159 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WALTERS, SUZAN M · 2021 to 2025
$927k
Examining HIV-related Stigma and HIV Testing Among Formerly Incarcerated African American YouthK01MH119942 · NIMH · UNIVERSITY OF LOUISVILLE · PI KERR, JELANI · 2020 to 2023
$639k
NIDA NIH HHS K01 DA053159NIDA NIH HHS R25 DA028567NIMH NIH HHS K01 MH119942
6 · The paper itself

Abstract

Recent evidence points to racial and ethnic disparities in drug-related deaths and health conditions. Informed by stigma, intersectionality, intersectional stigma, and fundamental cause theories, we aimed to explore whether intersectional stigma was a fundamental cause of health. We document key events and policies over time and find that when progress is made new mechanisms emerge that negatively affect health outcomes for Black and Hispanic persons. We then focus on intersectional stigma targeting Black and Hispanic persons who use drugs. We document that when a person, or group of people, occupy multiple stigmatized identities the processes of stigmatization and scapegoating are particularly persistent and pernicious since people and groups can be stigmatized and scapegoated on varying intersections. We propose that an intersectional stigma framework allows for a better understanding of observed patterns over time, thereby providing a better guide for policies and interventions designed to reduce disparities. As a framework, intersectional stigma aims to recognize that when different sources of stigma collide, a new set of circumstances is created for those who reside in the intersection. We conclude that intersectional stigma is a fundamental cause of health inequities and provide policy recommendations aimed at dismantling intersectional stigma processes and mitigating the effects of intersectional stigmas to ultimately promote better health outcomes for Black and Hispanic persons who use drugs.

Indexed as

drug usefundamental causeintersectional stigmarace and ethnicity

Identifiers

PMID37744082
PMCPMC10516303
OpenAlexW4322767419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.